SaudiCon

Kasim Kutay

Chief Executive Officer

Kasim Kutay has been Chief Executive Officer of Novo Holdings A/S in Denmark since September 2016. Novo Holdings manages the assets and wealth of the Novo Nordisk Foundation and is the controlling shareholder of Novo Nordisk and Novonesis; Kutay sits on the boards of both companies. Born in Alexandria in 1965 and raised between Lebanon and London, he is a UK national. He spent eighteen years at Morgan Stanley, where he rose to lead the European healthcare group, and from 2009 to 2016 was a Partner and member of the Global Management Committee at Moelis & Co. He holds a BSc in Economics and an MSc in the Politics of the World Economy from the London School of Economics and Political Science. He has served on the Board of Trustees of the Northwick Park Institute for Medical Research and on the Board of Governors and investment committee of SOAS in London, and currently serves on the board of CW+, the charity of Chelsea and Westminster Hospital NHS Foundation Trust.

Past appearances

1

Other speakers at Riyadh Global Medical Biotechnology Summit 2026

About Riyadh Global Medical Biotechnology Summit 2026